12/10: Red and Blue
Congress rushing for COVID relief agreement; Celebrating the first night of Hanukah
Pfizer
12/17: Red and Blue
Congress inching closer to stimulus relief deal; Losing the fight to unseat Sen. Susan Collins
12/15: Red and Blue
Sen. Mitch McConnell acknowledges Biden's win; Melania Trump visits children's hospital
Pfizer COVID vaccine found 94% effective in real-world study
Even after one dose, the vaccine proved very effective at preventing serious illness and death.
Biden visits Pfizer vaccine plant
Pfizer announced it expects to more than double the 5 million COVID-19 vaccine doses per week it's currently providing to the U.S. government. President Joe Biden visited a Pfizer vaccine plant and said that there would be enough COVID-19 vaccine doses available to all Americans by the end of July with those extra doses. Christina Ruffini reports.
Biden tells world leaders that "America is back"
President Biden detailed several foreign policy goals during a pair of major speeches on Friday. CBS News chief White House correspondent Nancy Cordes joins CBSN's Lana Zak to discuss the president's goals.
Biden visits Pfizer vaccine plant in Michigan
President Biden visited a Pfizer vaccine plant and delivered remarks in Kalamazoo, Michigan.
COVID vaccine trial for pregnant women
Pfizer is beginning the first clinical trial of its COVID-19 vaccine for pregnant women. Dr. Bob Lahita, professor of medicine New York Medical College and chairman of medicine at St. Joseph University Hospital, joined CBSN to discuss the safety of the vaccine during pregnancy as well as the importance of supporting global vaccination efforts.
2 pieces of good news on Pfizer's widely-used COVID vaccine
Drug company says vaccine doesn't need deep-freeze storage, which could ease distribution, as Israeli study shows 1st dose alone highly effective.
Pfizer launches first COVID-19 vaccine trial for pregnant women
Pregnant women face a greater risk of severe illness from COVID-19 and have been frustrated by a lack of clear guidance on vaccination.
Discussion continues on COVID relief bill
President Joe Biden's trip to a Pfizer facility has been cancelled, but discussion on the administration's coronavirus relief plan continues today. CBS News' Debra Alfarone joins CBSN AM to talk more about the state of economic recovery talks in Washington.
South Africa strain shows risk of unequal COVID "Vaccine Apartheid"
Experts warn that unless vaccines are rolled out in a timely fashion globally, the virus will continue to mutate, and that poses a risk to us all.
Inside Israel's COVID-19 vaccination campaign
A new study suggests two shots of the Pfizer vaccine helps to significantly slow the spread of COVID-19. The new information is coming from Israel, where more than 40% of the population has received at least one shot. Elizabeth Palmer reports.
States to receive more COVID-19 vaccine doses
The Biden administration is once again increasing its weekly supply of coronavirus vaccines to states. It comes as the U.S. picks up vaccination efforts to get ahead of dangerous new variants. Physician and immunotherapy scientist Dr. Leo Nissola joins CBSN to discuss the road to recovery.
U.S. increases vaccine supply amid variant fears
The White House said it is increasing vaccine supply to states to 13.5 million doses per week, a 57% increase, as fears of variants grow. Jonathan Vigliotti reports.
North Korea apparently tried to hack Pfizer for COVID vaccine info
A South Korean lawmaker told reporters about a briefing by his nation's spy agency.
AstraZeneca COVID vaccine shows promise
A new study from the United Kingdom says a single dose of the AstraZeneca COVID-19 vaccine can protect for months — and even more importantly, can slow transmission. Meg Oliver reports.
Top Pfizer scientist on COVID-19 vaccine
Pfizer announced it will supply 200 million doses of its COVID-19 vaccine for the U.S. by the end of May and is aiming to ship 2 billion doses globally this year. The vaccine is over 90% effective according to clinical trials conducted in 2020, but more testing needs to be done to see how well it protects against the new variants. Dr. Phil Dormitzer, who helped develop the vaccine as vice president and chief scientific officer of viral vaccines at Pfizer, joins CBSN to discuss.
COVID-19 variants spreading rapidly in U.S.
More contagious COVID-19 variants are spreading rapidly in the U.S. and a new study by the CDC finds the strain first found in the U.K. will become dominant here by March. Dr. Ron Elfenbein joins CBSN to discuss that plus President Biden's recent comments on the pandemic made in an exclusive interview with CBS News' Norah O'Donnell.
Expert on COVID-19 vaccine developments
Vaccination efforts around the world are picking up steam. Meanwhile, Pfizer announced it expects to cut production time for its COVID-19 vaccine by nearly 50%. CBS News senior foreign correspondent Elizabeth Palmer has an update on the worldwide effort, and David Montefiori, a professor and director of Duke University's Laboratory for AIDS Vaccine Research and Development, joins CBSN's Lana Zak to discuss.
Watch From Home? COVID-19 and the Super Bowl
Playing it safe: CBS New medical contributor Dr. David Agus joins "CBS This Morning: Saturday" to discuss if Super Bowl parties can be superspreader events and the latest with vaccines.
Israel's early vaccine data shows promise
Israel is taking an aggressive approach to vaccinating its population against COVID-19. The preliminary results are offering researchers hope in the midst of the pandemic. Isabel Kershner, a correspondent in Jerusalem for The New York Times, reported on that story and joins CBSN to discuss what she learned about the Pfizer vaccine's efficacy.
Drugmakers respond to COVID-19 variants
Johnson and Johnson has reported promising results from its single-dose coronavirus vaccine and plans to apply for emergency use authorization in early February. Meanwhile, the virus variant first identified in South Africa has now been found in the United States. CBS News' Mola Lenghi reports, and Dr. Bob Lahita spoke with CBSN's Anne-Marie Green and Vladimir Duthiers about the highly contagious new strain and the work drugmakers are doing to fight variants that continue to appear.
E.U. and U.K. tensions rise over vaccine supply
The United Kingdom has become the first European country to surpass 100,000 coronavirus deaths as shortfalls from European vaccine manufacturers pits the country against the European Union for the supply. The E.U. is threatening to prevent companies like Pfizer and AstraZeneca from exporting any vaccine orders until its own citizens receive doses, which also creates issues for developing nations in dire need of vaccinations. CBS News' Charlie D'Agata joins CBSN AM to discuss.
Biden on increasing COVID vaccines
President Joe Biden announced plans to buy 200 million more doses of COVID-19 vaccines and increase the distribution of shots to states across the country. "Help is on the way," he said. But he also warned the fight will take months and that people need to continue to wear masks. Watch his remarks.
Texas dad deported to Ghana was then forced to go to Mali, he says
Poll finds Democrats still boosted by voters' economic concerns
Lula wins 4th term as Brazil's president, but Bolsonaro rejects results
Live
Iran shrugs off Trump's attack threats, says diplomacy ongoing
Venezuela opposition leader María Corina Machado returns to country
Blanche says DOJ is "doing our own research" with Alaska challenge
More than 1,000 arrested in France as protesters and police clash
Jordan says 3 arrested in deadly attack on Greek Orthodox church
